643 related articles for article (PubMed ID: 31336616)
1. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases.
Agidigbi TS; Kim C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336616
[TBL] [Abstract][Full Text] [Related]
2. ROS signaling cascades: dual regulations for osteoclast and osteoblast.
Tao H; Ge G; Liang X; Zhang W; Sun H; Li M; Geng D
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1055-1062. PubMed ID: 33085739
[TBL] [Abstract][Full Text] [Related]
3. Iron-induced oxidative stress stimulates osteoclast differentiation via NF-κB signaling pathway in mouse model.
Wang X; Chen B; Sun J; Jiang Y; Zhang H; Zhang P; Fei B; Xu Y
Metabolism; 2018 Jun; 83():167-176. PubMed ID: 29378199
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases.
Callaway DA; Jiang JX
J Bone Miner Metab; 2015 Jul; 33(4):359-70. PubMed ID: 25804315
[TBL] [Abstract][Full Text] [Related]
5. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase gp91
Kang IS; Kim C
Sci Rep; 2016 Nov; 6():38014. PubMed ID: 27897222
[TBL] [Abstract][Full Text] [Related]
7. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species.
Jia P; Xu YJ; Zhang ZL; Li K; Li B; Zhang W; Yang H
J Orthop Res; 2012 Nov; 30(11):1843-52. PubMed ID: 22570238
[TBL] [Abstract][Full Text] [Related]
8. Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production.
Song D; Cao Z; Liu Z; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Dong S; Xu J
J Cell Physiol; 2018 Dec; 233(12):9674-9684. PubMed ID: 29968926
[TBL] [Abstract][Full Text] [Related]
9. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
[TBL] [Abstract][Full Text] [Related]
10. Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts.
Kim H; Kim IY; Lee SY; Jeong D
FEBS Lett; 2006 Oct; 580(24):5661-5. PubMed ID: 16996506
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation.
Koh JM; Lee YS; Kim YS; Kim DJ; Kim HH; Park JY; Lee KU; Kim GS
J Bone Miner Res; 2006 Jul; 21(7):1003-11. PubMed ID: 16813521
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
14. Role of lysosomal channel protein TPC2 in osteoclast differentiation and bone remodeling under normal and low-magnesium conditions.
Notomi T; Kuno M; Hiyama A; Nozaki T; Ohura K; Ezura Y; Noda M
J Biol Chem; 2017 Dec; 292(51):20998-21010. PubMed ID: 29084844
[TBL] [Abstract][Full Text] [Related]
15. Cerium ion promotes the osteoclastogenesis through the induction of reactive oxygen species.
Zhou L; Tang S; Yang L; Huang X; Zou L; Huang Y; Dong S; Zhou X; Yang X
J Trace Elem Med Biol; 2019 Mar; 52():126-135. PubMed ID: 30732873
[TBL] [Abstract][Full Text] [Related]
16. SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS.
Kim H; Lee YD; Kim HJ; Lee ZH; Kim HH
J Bone Miner Res; 2017 Feb; 32(2):397-406. PubMed ID: 27540894
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the alendronate and irradiation with a light-emitting diode (LED) on murine osteoclastogenesis.
Sohn HM; Ko Y; Park M; Kim B; Park JE; Kim D; Moon YL; Lim W
Lasers Med Sci; 2017 Jan; 32(1):189-200. PubMed ID: 27807651
[TBL] [Abstract][Full Text] [Related]
18. From macrophage to osteoclast - How metabolism determines function and activity.
Kubatzky KF; Uhle F; Eigenbrod T
Cytokine; 2018 Dec; 112():102-115. PubMed ID: 29914791
[TBL] [Abstract][Full Text] [Related]
19. Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production.
Kong L; Wang B; Yang X; Guo H; Zhang K; Zhu Z; Liu J; Hao D
Cell Physiol Biochem; 2017; 43(4):1425-1435. PubMed ID: 29017159
[TBL] [Abstract][Full Text] [Related]
20. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
